NEOGENOMICS INC - Common Stock, $0.01 par value (NEO)

CUSIP: 64049M209

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 7 signals
Share change
+5,977,220
Put/Call ratio
33%
SEC-reported price per share
$8.15
Number of holders
222
Value change
+$558,727
Number of buys
114
Open additional details 1 more signal available
Number of sells
127
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
128,549,415

Security key

64049M209

Report period

Q2 2022

Institutions

222

Top holders

10

Ownership snapshot

Top reported holders of NEO - NEOGENOMICS INC - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F 3/4/5 Highest disclosed value: $238,018,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $238.02M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $238.02M
VANGUARD GROUP INC $157.59M
WELLINGTON MANAGEMENT GROUP LLP $122.29M
Artisan Partners Limited Partnership $61.82M
BROWN ADVISORY INC $57.64M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$238,018,000
19,590,049 shares
— 31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$157,592,000
12,970,503 shares
— 31 Mar 2022
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
—
denominator unverified
$122,286,000
10,064,642 shares
— 31 Mar 2022
Artisan Partners Limited Partnership
13F
Company
13F
—
denominator unverified
$61,824,000
5,088,357 shares
— 31 Mar 2022
BROWN ADVISORY INC
13F
Company
13F
—
denominator unverified
$57,635,000
4,743,651 shares
— 31 Mar 2022
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$52,064,000
4,285,108 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
222
Shares
117,343,229
Rows available
222
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
262
Q2 2022 holders
222
Holder diff
-40
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .